295 related articles for article (PubMed ID: 10679921)
1. Two regions of homozygous deletion clusters at chromosome band 9p21 in human lung cancer.
Hamada K; Kohno T; Takahashi M; Yamazaki M; Yamazaki M; Tashiro H; Sugawara C; Ohwada S; Sekido Y; Minna JD; Yokota J
Genes Chromosomes Cancer; 2000 Mar; 27(3):308-18. PubMed ID: 10679921
[TBL] [Abstract][Full Text] [Related]
2. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR
Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033
[TBL] [Abstract][Full Text] [Related]
3. Identification of chromosome arm 9p as the most frequent target of homozygous deletions in lung cancer.
Sato M; Takahashi K; Nagayama K; Arai Y; Ito N; Okada M; Minna JD; Yokota J; Kohno T
Genes Chromosomes Cancer; 2005 Dec; 44(4):405-14. PubMed ID: 16114034
[TBL] [Abstract][Full Text] [Related]
4. Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions.
Cairns P; Okami K; King P; Bonacum J; Ahrendt S; Wu L; Mao L; Jen J; Sidransky D
Cancer Res; 1997 Dec; 57(23):5356-9. PubMed ID: 9393760
[TBL] [Abstract][Full Text] [Related]
5. Molecular processes of chromosome 9p21 deletions in human cancers.
Sasaki S; Kitagawa Y; Sekido Y; Minna JD; Kuwano H; Yokota J; Kohno T
Oncogene; 2003 Jun; 22(24):3792-8. PubMed ID: 12802286
[TBL] [Abstract][Full Text] [Related]
6. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
Lerman MI; Minna JD
Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
[TBL] [Abstract][Full Text] [Related]
7. The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis.
Toomes C; Jackson A; Maguire K; Wood J; Gollin S; Ishwad C; Paterson I; Prime S; Parkinson K; Bell S; Woods G; Markham A; Oliver R; Woodward R; Sloan P; Dixon M; Read A; Thakker N
Genes Chromosomes Cancer; 2003 Jun; 37(2):132-40. PubMed ID: 12696061
[TBL] [Abstract][Full Text] [Related]
8. Frequent homozygous deletions in lung cancer cell lines detected by a DNA marker located at 3p21.3-p22.
Yamakawa K; Takahashi T; Horio Y; Murata Y; Takahashi E; Hibi K; Yokoyama S; Ueda R; Takahashi T; Nakamura Y
Oncogene; 1993 Feb; 8(2):327-30. PubMed ID: 8381220
[TBL] [Abstract][Full Text] [Related]
9. Identification of a 428-kb homozygously deleted region disrupting the SEZ6L gene at 22q12.1 in a lung cancer cell line.
Nishioka M; Kohno T; Takahashi M; Niki T; Yamada T; Sone S; Yokota J
Oncogene; 2000 Dec; 19(54):6251-60. PubMed ID: 11175339
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene.
Wiest JS; Franklin WA; Otstot JT; Forbey K; Varella-Garcia M; Rao K; Drabkin H; Gemmill R; Ahrent S; Sidransky D; Saccomanno G; Fountain JW; Anderson MW
Cancer Res; 1997 Jan; 57(1):1-6. PubMed ID: 8988029
[TBL] [Abstract][Full Text] [Related]
11. Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer.
Stadler WM; Sherman J; Bohlander SK; Roulston D; Dreyling M; Rukstalis D; Olopade OI
Cancer Res; 1994 Apr; 54(8):2060-3. PubMed ID: 7513608
[TBL] [Abstract][Full Text] [Related]
12. Peculiar structure and location of 9p21 homozygous deletion breakpoints in human cancer cells.
Florl AR; Schulz WA
Genes Chromosomes Cancer; 2003 Jun; 37(2):141-8. PubMed ID: 12696062
[TBL] [Abstract][Full Text] [Related]
13. Homozygous deletions of methylthioadenosine phosphorylase (MTAP) are more frequent than p16INK4A (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC).
Schmid M; Malicki D; Nobori T; Rosenbach MD; Campbell K; Carson DA; Carrera CJ
Oncogene; 1998 Nov; 17(20):2669-75. PubMed ID: 9840931
[TBL] [Abstract][Full Text] [Related]
14. Homozygous deletions within 9p21-p22 identify a small critical region of chromosomal loss in human malignant mesotheliomas.
Cheng JQ; Jhanwar SC; Lu YY; Testa JR
Cancer Res; 1993 Oct; 53(20):4761-3. PubMed ID: 8402655
[TBL] [Abstract][Full Text] [Related]
15. Homozygous and hemizygous deletions of 9p centromeric to the interferon genes in lung cancer.
Mead LJ; Gillespie MT; Irving LB; Campbell LJ
Cancer Res; 1994 May; 54(9):2307-9. PubMed ID: 8162570
[TBL] [Abstract][Full Text] [Related]
16. Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer.
Konishi H; Sugiyama M; Mizuno K; Saito H; Yatabe Y; Takahashi T; Osada H; Takahashi T
Oncogene; 2003 Mar; 22(12):1892-905. PubMed ID: 12660825
[TBL] [Abstract][Full Text] [Related]
17. A homozygous deletion on chromosome 3 in a small cell lung cancer cell line correlates with a region of tumor suppressor activity.
Daly MC; Xiang RH; Buchhagen D; Hensel CH; Garcia DK; Killary AM; Minna JD; Naylor SL
Oncogene; 1993 Jul; 8(7):1721-9. PubMed ID: 8390035
[TBL] [Abstract][Full Text] [Related]
18. Homozygous deletions of CDKN2A caused by alternative mechanisms in various human cancer cell lines.
Raschke S; Balz V; Efferth T; Schulz WA; Florl AR
Genes Chromosomes Cancer; 2005 Jan; 42(1):58-67. PubMed ID: 15495191
[TBL] [Abstract][Full Text] [Related]
19. A novel tumor suppressor locus on chromosome 18q involved in the development of human lung cancer.
Takei K; Kohno T; Hamada K; Takita J; Noguchi M; Matsuno Y; Hirohashi S; Uezato H; Yokota J
Cancer Res; 1998 Aug; 58(16):3700-5. PubMed ID: 9721881
[TBL] [Abstract][Full Text] [Related]
20. Aberrant p16 expression is correlated with hemizygous deletions at the 9p21-22 chromosome region in non-small cell lung carcinomas.
Spanakis NE; Gorgoulis V; Mariatos G; Zacharatos P; Kotsinas A; Garinis G; Trigidou R; Karameris A; Tsimara-Papastamatiou H; Kouloukousa M; Manolis EN; Kittas C
Anticancer Res; 1999; 19(3A):1893-9. PubMed ID: 10470133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
